{"id":"W4381149358","doi":"10.3390/pharmaceutics15061764","title":"Expanding the Availability of Onasemnogene Abeparvovec to Older Patients: The Evolving Treatment Landscape for Spinal Muscular Atrophy","year":2023,"lang":"en","type":"review","venue":"Pharmaceutics","topic":"Neurogenetic and Muscular Disorders Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Cure SMA","keywords":"SMN1; Spinal muscular atrophy; SMA*; Medicine; Spinal cord; Motor neuron; Atrophy; Disease; Central nervous system; Muscle atrophy; Neuromuscular disease; Internal medicine; Bioinformatics; Biology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006069524,0.0004196372,0.001101137,0.0001532079,0.0002186659,0.00003313896,0.0003912261,0.0001199804,0.0001272085],"category_scores_gemma":[0.0004111991,0.0002104241,0.001055385,0.000566124,0.0001180087,0.00001849378,0.0001976019,0.0003017912,0.00007267082],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001955106,"about_ca_system_score_gemma":0.0004633431,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001376374,"about_ca_topic_score_gemma":0.000005494674,"domain_scores_codex":[0.9974474,0.0002499648,0.0006596118,0.0005037596,0.0006142727,0.0005250156],"domain_scores_gemma":[0.9979544,0.0004660386,0.0002073277,0.0008462091,0.0002735846,0.0002524716],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001337007,0.0004965507,0.0004121614,0.0176132,0.001344568,0.000009936713,0.000267228,0.000007883764,0.000028669,0.000008872992,0.001542213,0.978135],"study_design_scores_gemma":[0.001580505,0.0006652345,0.0001591505,0.002712796,0.003810448,0.000008579758,0.00009233939,0.0001054439,0.000187667,0.000005999618,0.9904575,0.000214296],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002430186,0.9887893,0.0001286047,0.0002511913,0.000287319,0.007778729,0.0001771146,0.00003608947,0.0001214436],"genre_scores_gemma":[0.001202451,0.9964552,0.0001243642,0.0002093589,0.0002704942,0.001146086,0.0001183245,0.0001149624,0.0003587733],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9889153,"threshold_uncertainty_score":0.8580844,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1822002210163219,"score_gpt":0.4743196806269877,"score_spread":0.2921194596106658,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}